Sep 9, 2020
Inherent Biosciences, a biotechnology company headquartered in Salt Lake City, UT, today announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to SARS-CoV2 (COVID-19) infection. The Small Business Innovation Research (SBIR) Phase I project aims to develop an on-site, clinical test to screen incoming patients potentially infected with COVID-19 and prioritize hospital resources and personnel based on a predicted infection severity and treatment response.
The variation in symptoms and outcomes for COVID-19 progression makes it challenging for health care workers to triage patients accurately. The development of a DNA methylation-based test to predict the severity of COVID-19 infection has tremendous potential for managing current and future pandemics.
“NSF is proud to support the technology of the future by thinking beyond incremental developments and funding the most creative, impactful ideas across all markets and areas of science and engineering,” said Andrea Belz, Division Director of the Division of Industrial Innovation and Partnerships at NSF. “With the support of our research funds, any deep technology startup or small business can guide basic science into meaningful solutions that address tremendous needs.”
Andy Olson, Co-founder and CEO of Inherent Biosciences, remarked: “We’re thrilled to announce this award, which will enable us to expand our discovery and commercialization pipeline into the area of infectious disease - a critical area as witnessed by the COVID-19 pandemic we’re living through.”
The award provides support for Inherent to generate a comprehensive dataset of white blood cell DNA methylation patterns, health history, and clinical data for patients infected with COVID-19. The company then uses artificial intelligence (AI) and machine learning to identify DNA methylation biomarkers predictive of disease severity and treatment response.
Kristin Brogaard, Ph.D., Co-founder and COO of the company, and Principal Investigator for the project added: “Our focus is translating epigenetic discoveries, specifically DNA methylation biomarkers, from research discoveries into commercial products that benefit consumers, patients and health care providers.”
Inherent has already translated one epigenetic discovery into a commercial product. The company’s first product called “Path” (PathFertility.com) is for couples trying to conceive. Path is marketed directly to consumers as a general wellness sperm DNA test related to maintaining or encouraging a general state of health, specifically male reproductive health.
About Inherent Biosciences - Inherent Biosciences, Inc. is a molecular diagnostics company at the intersection of epigenetics and AI. Inherent believes that guesswork and trial-and-error medicine lead to severe pain and suffering. Inherent’s vision is to revolutionize trial and error medicine and restore hope. The company does this by discovering what is inherent in our biology about the unexplained and translating discoveries into personal insights that inform actions. Learn more at www.inherentbio.com or connect on LinkedIn.
Contact: Inherent Biosciences, Inc.
Andy Olson, CEO
Phone: (509) 496-1204
Email: [email protected]
Bali travel experience: An Indian man’s account of a two-month trip to Bali has sparked an online conversation. He spent one month exploring villages across the island and another month living by the beach. His relaxed beachside routine included daily walks, yoga sessions and massages. The experience offered a glimpse into a slower approach to travel and taking a break from everyday life. The story also prompted discussions about longer trips and slow travel.
The ED alleges that the resulting entity repaid about Rs 7,800 crore, including principal and interest, to Genpact Luxembourg between 2018 and 2023 from the reserves of the Indian business. It has claimed that the transactions amounted to round-tripping and violated Section 4 of FEMA, which restricts Indian residents from holding foreign exchange, securities or assets outside India.
The ED alleges that the resulting entity repaid about Rs 7,800 crore, including principal and interest, to Genpact Luxembourg between 2018 and 2023 from the reserves of the Indian business. It has claimed that the transactions amounted to round-tripping and violated Section 4 of FEMA, which restricts Indian residents from holding foreign exchange, securities or assets outside India.
The quote of the day by Audrey Hepburn "The beauty of a woman is not in the clothes she wears, the figure that she carries, or the way she combs her hair. The beauty of a woman is seen in her eyes, because that is the doorway to her heart, the place where love resides" offers a timeless perspective that woman's appearance, clothes and hairstyle do not define her completely.
The Isdal Woman mystery began in November 1970, when a burned body was discovered in Norway’s remote Isdalen Valley near Bergen. Investigators found unusual clues, including belongings with identifying labels removed, two suitcases containing wigs and clothes, and notes that appeared to record hotel stays under different names. Her identity was never established, while the circumstances surrounding her death led to theories ranging from espionage to other unexplained possibilities. Although the case was closed in 1971, renewed investigations decades later examined her background, movements and physical evidence. Yet 56 years later, her identity and the full story remain unresolved.
The current provision under Section 2(z) of the Act mandates that proceeds from SEZ-to-DTA supplies of services must be realised in foreign exchange, although there is no such requirement for the supply of goods to DTA entities.
The Hubble telescope captured images of spiral galaxy NGC 4698. Its central bulge is tilted at an unusual angle to the main disk. Astronomers suggest this structure resulted from past gas absorption or a minor merger. This galaxy is located in the Virgo Cluster, approximately 55 million light-years away. Further observations will clarify NGC 4698's complex cosmic history.
A genetically engineered chestnut has cleared a major hurdle a century after an invasive fungus almost wiped out one of America’s most important forest trees. Scientists are making attempts to revive what was destroyed in the 1900s. Four billion American chestnut trees died. The ecosystem where they flourished now has barely any left. So, can a 2026 breakthrough bring American chestnuts back to life? Let's find out.
Jennifer Garner ventured into the food industry by being a co-founder of Once Upon a Farm in 2017. The company made waves in February 2026 with its initial public offering, where Garner's investment was initially valued at about $64 million. By August 2026, her stakes had decreased to around $55 million amid ongoing trading on the New York Stock Exchange.
The agriculture ministry is preparing for the upcoming rabi season with states. This preparation addresses concerns over soil moisture and reservoir status for winter crops. The ministry will hold a national Rabi Conference to discuss crop strategies for affected areas. States are assessing district conditions and identifying farmers needing alternative crop interventions. These measures aim to mitigate potential impacts on food inflation from inadequate planting.
State's Cabinet minister Manoj Pandey recently organised a Shiv Puran katha under the guidance of Pandit Pradeep Mishra of Madhya Pradesh in his assembly constituency Unchahar, located in the Raebareli district. Uttar Pradesh chief minister Yogi Adityanath, deputy chief ministers Keshav Prasad Maurya and Brajesh Pathak and several state ministers and leaders attended the religious gathering.
A large Aspen mansion, once rented by Rihanna, sold for $63.5 million. This property had previously been listed for as much as $79 million. The sale occurred as Aspen’s luxury housing market experienced a slowdown. Home sales above $10 million saw a significant decrease compared to last year. Buyers are now showing more resistance to high luxury home prices.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.